Doctor Madhu Chintala
Spring House (United States of America)
Differential impact of milvexian, an investigational oral FXIa inhibitor vs apixaban and dabigatran on thrombin generation in human donor plasma in vitro
Event: ESC Congress 2022
Topic: Thrombosis, Bleeding
Session: Clinical and basic science insights in vascular disease
JNJ-9375, a novel exosite 1 thrombin inhibitor does not increase bleeding in a spontaneous gastrointestinal (GI) bleeding model in mice with a mutation of the Adenomatous polyposis coli (Apc) gene
Event: ESC Congress 2018
Topic: Thrombosis, Bleeding
Session: Platelets, haemostasis and coagulation
